Exagen makes AVISE brand blood tests that help doctors diagnose autoimmune and related rheumatic diseases. It last closed at $3.61 on Nov 20, down 5.00% on the day. The next earnings report for XGN is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, XGN reported EPS of -$0.25 on revenue of $18.4M, with revenue up 6.8% from a year ago. Over its last 8 reports the stock moved an average of 17.0% the session after earnings. Over the last 12 months XGN insiders bought $569K of stock on the open market and sold $1.3M, according to SEC Form 4 filings.
AI Auto Pilots
Is XGN in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold XGN.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on XGNStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
XGN · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, oversold
The stock is 72% below its 20 day and 104% below its 50 day average. It is 42% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 27), oversold. The nearest support is the Pivot S1 at $3.43, and the nearest resistance the Pivot at $3.66.
Short trendBearish
Long trendBullish
MomentumWeak
StretchOversold
VolatilityHigh, 18.8%/day
Key levels
$9.2252 week high+155.4%
$7.3650 day average+103.9%
$6.67100 day average+84.8%
$6.2220 day average+72.3%
$5.13200 day average+42.1%
$4.85Swing high (Jun 15)+34.3%
$3.85Pivot R1+6.6%
$3.66Pivot+1.4%
$3.61Last close
$3.43Pivot S1−5.0%
$2.5952 week low−28.3%
Indicators
RSI (14)
27.45
Oversold below 30
Oversold
MACD
-1.15
Below its signal line
Bearish
Stochastic
4.6
Near the bottom of its range
Oversold
ADX (14)
38.9
Trending down
Williams %R
-97.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-96.0
Oversold below −100, overbought above 100
Neutral
Rate of change
−37.9%
Change over 10 sessions
Bearish
ATR (14)
$0.68
Typical daily range, 18.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend, nearing oversold
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityHigh, 34.8%/day
Key levels
$9.2252 week high+155.4%
$7.3650 day average+103.9%
$6.67100 day average+84.8%
$6.2220 day average+72.3%
$5.13200 day average+42.1%
$4.85Swing high (Jun 15)+34.3%
$3.85Pivot R1+6.6%
$3.66Pivot+1.4%
$3.61Last close
$3.43Pivot S1−5.0%
$2.5952 week low−28.3%
Indicators
RSI (14)
37.43
Weak, oversold below 30
Neutral
MACD
0.13
Below its signal line
Bearish
Stochastic
11.6
Near the bottom of its range
Oversold
ADX (14)
31.4
Trending down
Williams %R
-97.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-143.1
Oversold below −100, overbought above 100
Oversold
Rate of change
−48.6%
Change over 10 sessions
Bearish
ATR (14)
$1.26
Typical daily range, 34.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for XGN
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how XGN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow XGN usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for XGNHow many large options trades hit XGN, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in XGN in the last 90 days.
From SEC Form 4 filings by XGN's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether XGN is in one of them and how their past XGN trades turned out.
Exagen is a medical technology company based in Vista, California, that makes diagnostic tests for autoimmune and related rheumatic diseases. Its main product line, sold under the AVISE brand, includes AVISE CTD, which helps clinicians tell apart conditions with overlapping symptoms, such as lupus and rheumatoid arthritis. Its tests are used mainly by rheumatologists, with primary care physicians, other specialists, hospitals and healthcare systems also among its customers. The company runs its own clinical laboratory to process the tests.